SF500
Overview
SF500 is a biotechnology-focused investment firm and company builder based in Rosario, Argentina, that transforms scientific projects into globally scalable startups.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| PILL.AR | - | Pre Seed | Lead |
| BioMetallum | Jun 2023 | Seed | Lead |
| Biotalife Skin | Aug 2022 | Accelerator | Lead |
| Unibaio | Mar 2023 | Seed | Lead |
| Tintte | Nov 2023 | Seed | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is SF500 based?
SF500 is headquartered in Rosario, Argentina.
When was SF500 founded?
SF500 was founded in 2021.
How many portfolio companies does SF500 have?
SF500 has 11 portfolio companies in Caplight's dataset.
What are some companies in SF500's portfolio?
Portfolio companies visible on Caplight include PILL.AR, BioMetallum, Biotalife Skin, Unibaio, Tintte.
What was SF500's most recent investment shown here?
SF500's most recent investment in this portfolio sample was in Tintte in 2023.
What sectors does SF500 focus on?
SF500 focuses on Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Enterprise Software, Energy & Sustainability, Frontier & Industrial Tech, Consumer & Commerce, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does SF500 focus on?
SF500 typically invests at the Early stage.